MetaCap

IRulya Therapeutics Quarterly Income Statement

NASDAQ: IRLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

39.88-0.06 (-0.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IRulya Therapeutics revenue and earnings

IRulya Therapeutics reported a net loss of $27.7 million, compared with a loss of $13.4 million a year earlier. Diluted earnings per share came in at -$2.31.

Summary generated from market data by MetaCap's automated system. Methodology

IRulya Therapeutics income statement (quarterly)

IRulya Therapeutics quarterly income statement
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Operating Expenses13.14M79.78M14.59M19.35M13.43M10.43M14.86M12.01M5.86M28.19M11.22M9.92M
Research & Development5.85M5.46M6.84M12.60M8.08M6.55M8.14M5.83M4.92M4.15M3.70M3.43M
Operating Income-13.14M-79.78M-14.59M-19.35M-13.43M-10.43M-14.86M-12.01M-5.86M-28.19M-11.22M-9.92M
Other Income (Expense)-1.62M152.00K1.72M660.00K-58.00K-29.00K-87.00K-518.00K150.00K91.00K-399.00K402.00K
Pretax Income——————-14.98M———-11.12M—
Income Tax-302.00K75.00K-5.34M3.15M-46.00K67.00K47.00K7.00K13.00K36.00K31.00K51.00K
Net Income-27.74M-75.49M35.91M-39.46M-13.44M-16.05M-15.03M-12.46M-5.49M-27.73M-11.15M-8.89M
Net Income growth (YoY)————————————
EPS (Basic)-2.31-12.313.60120.32-49.83-68.75-3.42-0.28-0.13-0.64-0.26-0.21
EPS (Diluted)-2.31-12.312.88120.32-49.83-68.75-3.42-0.28-0.13-0.64-0.26-0.21
Shares Outstanding (Basic)12.00M6.13M9.12M—269.76K233.43K4.39M—43.16M43.10M43.01M—
Shares Outstanding (Diluted)12.00M6.13M9.19M—269.76K233.43K4.39M—43.16M43.10M43.01M—
EBITDA-13.13M-79.74M-14.55M-19.31M-13.39M-10.39M-14.83M-12.00M-5.78M-28.15M-11.18M-9.62M

This table shows 12 quarterly periods of IRulya Therapeutics's income statement, from Q3 2026 back to Q4 2023, across 13 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow IRLA's reporting calendar. What is a income statement?

More financial data